Labcorp
927 hedge funds and large institutions have $17.1B invested in Labcorp in 2024 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 320 increasing their positions, 342 reducing their positions, and 102 closing their positions.
25% more call options, than puts
Call options by funds: $64.3M | Put options by funds: $51.3M
6% less repeat investments, than reductions
Existing positions increased: 320 | Existing positions reduced: 342
3% less funds holding
Funds holding: 956 → 927 (-29)
3.81% less ownership
Funds ownership: 97.07% → 93.26% (-3.8%)
9% less capital invested
Capital invested by funds: $18.7B → $17.1B (-$1.62B)
19% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 102
53% less funds holding in top 10
Funds holding in top 10: 15 → 7 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$132M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$85M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$83M |
| 4 |
CS
Cannell & Spears
New York
|
+$74.4M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$60.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$567M |
| 2 |
BlackRock
New York
|
-$232M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$203M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$89.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$83M |
LH Hedge Fund Activity: Q1 2024 in Review
927 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q1 2024, worth a combined $17.1B — down 8.6% from $18.7B a quarter earlier.
Sellers outnumbered buyers: 102 funds closed out of LH and 83 opened new positions — a net loss of 19 holders — while 342 trimmed existing stakes and 320 added.
The largest buyer was Allspring Global Investments, adding an estimated $132M. The largest seller was Morgan Stanley, cutting an estimated $567M.
- 927 institutional investors held Labcorp (LH) as of Q1 2024, down from 956 in Q4 2023.
- Funds reported $17.1B of Labcorp stock for Q1 2024, down 8.6% quarter-over-quarter.
- 83 funds opened new Labcorp positions in Q1 2024 and 102 closed out, a net change of -19 holders.
- The largest Labcorp buyer in Q1 2024 was Allspring Global Investments, an estimated $132M added.
- The largest Labcorp seller in Q1 2024 was Morgan Stanley, an estimated $567M sold.
Based on aggregated 13F filings for Q1 2024.